Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the onset and duration of action of AC-170 0.24% compared to vehicle in the prevention of the signs and symptoms of allergic conjunctivitis in the conjunctival...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Aciex Therapeutics, Inc.
NCT06686472 · Allergic Conjunctivitis
NCT05839938 · Allergic Conjunctivitis
NCT05186025 · Allergic Rhinitis Due to Pollen, Allergic Conjunctivitis, and more
NCT01471184 · Allergic Rhinitis, Allergic Conjunctivitis
NCT06602726 · Allergic Conjunctivitis
Ora, Inc.
Andover, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions